Featuring a slide presentation and related discussion from Dr Philip A Philip, including the following topics:
- Comprehensive biomarker analysis for patients diagnosed with colorectal cancer (CRC) (0:00)
- Selection and sequencing of systemic therapy for patients with metastatic CRC (11:48)
- Prevalence of claudin-18.2 in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer (22:31)
- Emerging systemic therapies for hepatocellular carcinoma (24:49)
- Management of advanced biliary tract cancers (30:04)
- Activity of NALIRIFOX (liposomal irinotecan/oxaliplatin/leucovorin/fluorouracil) for treatment-naïve metastatic pancreatic cancer (35:35)
CME information and select publications